EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $248,579 | -47.4% | 12,787 | -23.3% | 0.00% | -50.0% |
Q1 2023 | $472,843 | +1.3% | 16,667 | +4.4% | 0.00% | 0.0% |
Q4 2022 | $466,803 | +12.2% | 15,970 | +1.4% | 0.00% | 0.0% |
Q3 2022 | $416,000 | -52.3% | 15,745 | -19.9% | 0.00% | -42.9% |
Q2 2022 | $873,000 | -0.5% | 19,655 | +10.8% | 0.01% | +40.0% |
Q1 2022 | $877,000 | +5.4% | 17,732 | +8.6% | 0.01% | +25.0% |
Q4 2021 | $832,000 | -38.0% | 16,330 | -32.1% | 0.00% | -50.0% |
Q3 2021 | $1,342,000 | +85.9% | 24,057 | +42.6% | 0.01% | +100.0% |
Q2 2021 | $722,000 | +248.8% | 16,871 | +290.6% | 0.00% | +100.0% |
Q2 2020 | $207,000 | -96.4% | 4,319 | -96.5% | 0.00% | -96.6% |
Q1 2020 | $5,725,000 | -23.9% | 124,463 | -0.6% | 0.06% | +3.6% |
Q4 2019 | $7,520,000 | +9.2% | 125,166 | +2.8% | 0.06% | +1.8% |
Q3 2019 | $6,887,000 | +1.1% | 121,746 | -0.5% | 0.06% | 0.0% |
Q2 2019 | $6,813,000 | +10.2% | 122,368 | -0.1% | 0.06% | +10.0% |
Q1 2019 | $6,183,000 | +23.1% | 122,456 | -1.8% | 0.05% | +16.3% |
Q4 2018 | $5,022,000 | -17.2% | 124,643 | +42.5% | 0.04% | +7.5% |
Q3 2018 | $6,064,000 | -31.2% | 87,469 | -24.9% | 0.04% | -32.2% |
Q2 2018 | $8,811,000 | -12.3% | 116,451 | -38.9% | 0.06% | +136.0% |
Q1 2018 | $10,049,000 | +38.1% | 190,705 | +40.0% | 0.02% | +47.1% |
Q4 2017 | $7,276,000 | -13.9% | 136,196 | -3.9% | 0.02% | -15.0% |
Q3 2017 | $8,449,000 | -19.0% | 141,662 | +7.2% | 0.02% | -28.6% |
Q2 2017 | $10,428,000 | +231.8% | 132,173 | +248.9% | 0.03% | +211.1% |
Q1 2017 | $3,143,000 | +0.8% | 37,883 | -3.5% | 0.01% | 0.0% |
Q4 2016 | $3,117,000 | -40.7% | 39,275 | -47.7% | 0.01% | -43.8% |
Q3 2016 | $5,256,000 | +223.6% | 75,089 | +79.4% | 0.02% | +220.0% |
Q2 2016 | $1,624,000 | +8.8% | 41,855 | +13.6% | 0.01% | 0.0% |
Q1 2016 | $1,492,000 | -20.0% | 36,850 | +75.1% | 0.01% | 0.0% |
Q4 2015 | $1,866,000 | +14.9% | 21,046 | -4.1% | 0.01% | 0.0% |
Q3 2015 | $1,624,000 | – | 21,935 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |